Literature DB >> 18596852

Heart failure with a normal left ventricular ejection fraction: diastolic heart failure.

William C Little1.   

Abstract

A reduced left ventricular ejection fraction measured by echocardiography in a patient with clinical features of heart failure demonstrates that the patient has a cardiac abnormality and that the clinical picture is, in fact, due to heart failure. As such, a reduced ejection fraction (< 0.30 or 0.35) has been used as entry criteria for almost all the large clinical trials that guide our therapy of patients with heart failure. However, it has been recently recognized that a substantial and increasing proportion of patients with heart failure have a normal ejection fraction (> 0.50). Such patients are typically elderly women with systolic hypertension. These patients are subject to the sudden development of pulmonary congestion (flash pulmonary edema). The finding of heart failure in patients with a normal ejection fraction has focused attention on the role of diastolic dysfunction in producing symptomatic heart failure. The optimal treatment of patients with heart failure and normal ejection fraction has not yet been defined, but the control of systolic hypertension and the avoidance of fluid overload are important.

Entities:  

Mesh:

Year:  2008        PMID: 18596852      PMCID: PMC2394690     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  17 in total

Review 1.  Hypertensive pulmonary oedema is due to diastolic dysfunction.

Authors:  W C Little
Journal:  Eur Heart J       Date:  2001-11       Impact factor: 29.983

2.  The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1997-05       Impact factor: 29.983

3.  Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure.

Authors:  Dalane W Kitzman; William C Little; Peter H Brubaker; Roger T Anderson; W Gregory Hundley; Christian T Marburger; Bridget Brosnihan; Timothy M Morgan; Kathryn P Stewart
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

4.  Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.

Authors:  Steffen Brucks; William C Little; Tania Chao; Dalane W Kitzman; Deborah Wesley-Farrington; Sanjay Gandhi; Zakariya K Shihabi
Journal:  Am J Cardiol       Date:  2005-03-01       Impact factor: 2.778

5.  Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report.

Authors:  Hidekatsu Fukuta; David C Sane; Steffen Brucks; William C Little
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

6.  Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function.

Authors:  Mei Wang; Gabriel Yip; Cheuk-Man Yu; Qing Zhang; Yan Zhang; Deko Tse; Shun-Ling Kong; John E Sanderson
Journal:  J Am Coll Cardiol       Date:  2005-01-18       Impact factor: 24.094

7.  The pathogenesis of acute pulmonary edema associated with hypertension.

Authors:  S K Gandhi; J C Powers; A M Nomeir; K Fowle; D W Kitzman; K M Rankin; W C Little
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

8.  Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise.

Authors:  J G Warner; D C Metzger; D W Kitzman; D J Wesley; W C Little
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

9.  Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis.

Authors:  C S Rihal; R A Nishimura; L K Hatle; K R Bailey; A J Tajik
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

10.  Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction.

Authors:  William C Little; Deborah J Wesley-Farrington; John Hoyle; Steffen Brucks; Scott Robertson; Dalane W Kitzman; Che-Ping Cheng
Journal:  J Cardiovasc Pharmacol       Date:  2004-02       Impact factor: 3.105

View more
  7 in total

1.  Different Sequences of Fractionated Low-Dose Proton and Single Iron-Radiation-Induced Divergent Biological Responses in the Heart.

Authors:  Sharath P Sasi; Xinhua Yan; Marian Zuriaga-Herrero; Hannah Gee; Juyong Lee; Raman Mehrzad; Jin Song; Jillian Onufrak; James Morgan; Heiko Enderling; Kenneth Walsh; Raj Kishore; David A Goukassian
Journal:  Radiat Res       Date:  2017-06-14       Impact factor: 2.841

Review 2.  Cardiac metabolic remodelling in chronic kidney disease.

Authors:  Nikayla Patel; Muhammad Magdi Yaqoob; Dunja Aksentijevic
Journal:  Nat Rev Nephrol       Date:  2022-05-30       Impact factor: 42.439

3.  Preliminary investigation of multiparametric strain Z-score (MPZS) computation using displacement encoding with simulated echoes (DENSE) and radial point interpretation method (RPIM).

Authors:  Julia Kar; Brian Cupps; Xiaodong Zhong; Danielle Koerner; Kevin Kulshrestha; Samuel Neudecker; Jennifer Bell; Heidi Craddock; Michael Pasque
Journal:  J Magn Reson Imaging       Date:  2016-03-31       Impact factor: 4.813

4.  Weighted correlation network bioinformatics uncovers a key molecular biosignature driving the left-sided heart failure.

Authors:  Jiamin Zhou; Wei Zhang; Chunying Wei; Zhiliang Zhang; Dasong Yi; Xiaoping Peng; Jingtian Peng; Ran Yin; Zeqi Zheng; Hongmei Qi; Yunfeng Wei; Tong Wen
Journal:  BMC Med Genomics       Date:  2020-07-03       Impact factor: 3.063

5.  The Hippo in the Clinic: An Ancient Signaling Pathway That Regulates Growth and Development Confronts a Modern Pandemic of Obesity, Diabetes, and Heart Failure.

Authors:  Sheldon H Gottlieb
Journal:  JACC Basic Transl Sci       Date:  2019-09-23

6.  TNM-like classification: a new proposed method for heart failure staging.

Authors:  Francesco Fedele; Maria Chiara Gatto; Alessandra D'Ambrosi; Massimo Mancone
Journal:  ScientificWorldJournal       Date:  2013-11-24

7.  Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.

Authors:  Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm; Nikolaus Marx
Journal:  Circulation       Date:  2021-03-15       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.